Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

New biopharma start-up at Lille's Institut Pasteur

10 Aug 2016 | Health Nutrition, A region on the move

A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

Immune InsighT at Lille's Institut Pasteur

Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

 

Source: Lille's Institut Pasteur

Back to news

News

Heineken brings €5.5 m in cutting-edge technology to Hauts-de-France

The brewer has invested more than €70 m in the Hauts-de-France Region in nearly a decade. Let’s take a look at its newest upgrade to the Pélican brewery, a strategic production site in Mons-en-Baroeul.

The EPMA opens an office in Hauts-de-France

The European Powder Metallurgy Association is setting up shop in Chantilly (Oise <Hauts-de-France). Interview with Executive Director Lionel Aboussouan on why the EPMA chose Chantilly and its future...

All news